+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Endoscopic Retrograde Cholangiopancreatography Market by Product, Procedure, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674534
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Endoscopic Retrograde Cholangiopancreatography Market grew from USD 1.91 billion in 2023 to USD 2.05 billion in 2024. It is expected to continue growing at a CAGR of 7.59%, reaching USD 3.20 billion by 2030.

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a specialized medical procedure combining endoscopy and fluoroscopy to diagnose and treat conditions associated with the bile and pancreatic ducts. It is primarily used to remove bile duct stones, insert stents, treat leaks, or collect tissue for biopsy. The global demand for ERCP is driven by an increasing prevalence of gastrointestinal disorders, pancreatic diseases, and a growing elderly population susceptible to such conditions. Technological advancements in endoscopic devices and increasing healthcare expenditure are propelling the use of these procedures. The market is seeing an uptick in growth from rising investments in research for better visual and therapeutic technologies. Key opportunities lie in enhancing minimally invasive procedures and developing advanced visualization systems, thus offering faster recovery and reduced procedural times. Increased focus on artificial intelligence to improve procedural precision can be another growth avenue. However, stringent regulatory guidelines, high procedural costs, and a shortage of trained professionals pose significant challenges to market growth. The cumbersome nature of the procedure and the potential for adverse outcomes such as pancreatitis also limit wider adoption. Innovations in developing disposable endoscopes and more user-friendly ERCP equipment present potential growth opportunities. Business growth in this area may significantly benefit from collaborations with technology firms to integrate AI and machine learning to improve accuracy and efficiency. To navigate this market effectively, companies should invest in training healthcare providers and focus on emerging markets, where healthcare infrastructure improvements are creating demand. The nature of the ERCP market is dynamic, with scope for continual innovation, particularly in enhancing procedural safety and efficacy, ensuring compliance with evolving healthcare standards, and expanding patient accessibility.

Understanding Market Dynamics in the Endoscopic Retrograde Cholangiopancreatography Market

The Endoscopic Retrograde Cholangiopancreatography Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing prevalence of gastrointestinal and chronic biliary disorders
    • Proliferation in healthcare expenditures coupled with enhancing healthcare infrastructures worldwide
    • Rising preference for minimally invasive surgeries coupled with increasing consumer awareness toward advanced endoscopic techniques
  • Market Restraints
    • High costs associated with endoscopic retrograde cholangiopancreatography devices
  • Market Opportunities
    • Significant research and development activities with heavy investments for advancement of endoscopic procedures
    • Ongoing surge in deployment of endoscopic retrograde cholangiopancreatography solutions with favorable governmental actions
  • Market Challenges
    • Scarcity of skilled professionals and trained endoscopists across the globe

Exploring Porter’s Five Forces for the Endoscopic Retrograde Cholangiopancreatography Market

Porter’s Five Forces framework further strengthens the insights of the Endoscopic Retrograde Cholangiopancreatography Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Endoscopic Retrograde Cholangiopancreatography Market

External macro-environmental factors deeply influence the performance of the Endoscopic Retrograde Cholangiopancreatography Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Endoscopic Retrograde Cholangiopancreatography Market

The Endoscopic Retrograde Cholangiopancreatography Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Endoscopic Retrograde Cholangiopancreatography Market

The Endoscopic Retrograde Cholangiopancreatography Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Endoscopic Retrograde Cholangiopancreatography Market

The Endoscopic Retrograde Cholangiopancreatography Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endoscopic Retrograde Cholangiopancreatography Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Machida Endoscope Co., Ltd, Medi-Globe GmbH, Medtronic PLC, Merit Medical Systems, Inc., Olympus Corporation, Ottomed Endoscopy, PENTAX Medical, Richard Wolf GmbH, Smith & Nephew PLC, STERIS, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Endoscopic Retrograde Cholangiopancreatography Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Endoscopes
    • Endotherapy Devices
      • Balloons
      • Baskets
      • Cannulas
      • Catheters
      • Forceps
      • Guiding Wires
      • Lithotripter
      • Snares
      • Sphincterotomes
      • Stents
    • Energy Devices
    • Visualization Systems
  • Procedure
    • Biliary Dilatation
    • Biliary Sphincterotomy
    • Biliary Stenting
    • Pancreatic Duct Dilatation
    • Pancreatic Duct Stenting
    • Pancreatic Sphincterotomy
  • End-User
    • Ambulatory Surgery Centres & Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Endoscopic Retrograde Cholangiopancreatography Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of gastrointestinal and chronic biliary disorders
5.1.1.2. Proliferation in healthcare expenditures coupled with enhancing healthcare infrastructures worldwide
5.1.1.3. Rising preference for minimally invasive surgeries coupled with increasing consumer awareness toward advanced endoscopic techniques
5.1.2. Restraints
5.1.2.1. High costs associated with endoscopic retrograde cholangiopancreatography devices
5.1.3. Opportunities
5.1.3.1. Significant research and development activities with heavy investments for advancement of endoscopic procedures
5.1.3.2. Ongoing surge in deployment of endoscopic retrograde cholangiopancreatography solutions with favorable governmental actions
5.1.4. Challenges
5.1.4.1. Scarcity of skilled professionals and trained endoscopists across the globe
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Endoscopic Retrograde Cholangiopancreatography Market, by Product
6.1. Introduction
6.2. Endoscopes
6.3. Endotherapy Devices
6.4.1. Balloons
6.4.2. Baskets
6.4.3. Cannulas
6.4.4. Catheters
6.4.5. Forceps
6.4.6. Guiding Wires
6.4.7. Lithotripter
6.4.8. Snares
6.4.9. Sphincterotomes
6.4.10. Stents
6.4. Energy Devices
6.5. Visualization Systems
7. Endoscopic Retrograde Cholangiopancreatography Market, by Procedure
7.1. Introduction
7.2. Biliary Dilatation
7.3. Biliary Sphincterotomy
7.4. Biliary Stenting
7.5. Pancreatic Duct Dilatation
7.6. Pancreatic Duct Stenting
7.7. Pancreatic Sphincterotomy
8. Endoscopic Retrograde Cholangiopancreatography Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centres & Clinics
8.3. Hospitals
9. Americas Endoscopic Retrograde Cholangiopancreatography Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. B. Braun Melsungen AG
13.1.2. Becton, Dickinson and Company
13.1.3. Boston Scientific Corporation
13.1.4. CONMED Corporation
13.1.5. Cook Group Incorporated
13.1.6. Fujifilm Holdings Corporation
13.1.7. Johnson & Johnson Services, Inc.
13.1.8. KARL STORZ SE & Co. KG
13.1.9. Machida Endoscope Co., Ltd
13.1.10. Medi-Globe GmbH
13.1.11. Medtronic PLC
13.1.12. Merit Medical Systems, Inc.
13.1.13. Olympus Corporation
13.1.14. Ottomed Endoscopy
13.1.15. PENTAX Medical
13.1.16. Richard Wolf GmbH
13.1.17. Smith & Nephew PLC
13.1.18. STERIS
13.1.19. Stryker Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET RESEARCH PROCESS
FIGURE 2. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2023 VS 2030
FIGURE 3. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET DYNAMICS
FIGURE 7. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
FIGURE 10. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

The leading players in the Endoscopic Retrograde Cholangiopancreatography Market, which are profiled in this report, include:
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group Incorporated
  • Fujifilm Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Machida Endoscope Co., Ltd
  • Medi-Globe GmbH
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Olympus Corporation
  • Ottomed Endoscopy
  • PENTAX Medical
  • Richard Wolf GmbH
  • Smith & Nephew PLC
  • STERIS
  • Stryker Corporation

Methodology

Loading
LOADING...

Table Information